Assessment of GI Function to a Large Test Meal by Non-invasive Imaging
NCT03007433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2017-01-02
Summary
Dyspeptic symptoms such as abdominal pain, bloating and nausea after a meal are common; however the cause of these problems in many patients is often unclear despite medical investigation. This is because "dyspeptic symptoms" are only rarely related to acid reflux, stomach ulcers or cancer that can be diagnosed by endoscopy. Rather, the cause is abnormal stomach function, so-called "functional dyspepsia", a condition in which the digestive system does not function normally after a meal. Gastric scintigraphy is the standard investigation of stomach function in patients with this condition. It involves eating a small test meal that includes a tiny dose of radioactive material so that the movement of food can be visualised as it empties from the stomach. An important limitation of this approach is that symptoms are rarely caused and delayed emptying after a small meal is present only in a minority of patients and, thus, the ability of this investigation to explain the cause of symptoms or guide medical treatment is limited.
This research project is designed to compare three new investigations of stomach function using a relatively large meal. This information will help to explain the causes of symptoms after a meal. The investigations to be tested include: (1) Nutrient Drink Test, (2) Gastric Scintigraphy and (3) Magnetic Resonance Imaging. All three tests are safe, easy to perform and non-invasive (i.e. do not involve inserting catheters through the nose and into the stomach or taking blood). The results should provide more useful information to doctors looking after patients with dyspeptic symptoms.
This study will compare test results from healthy volunteers, with patients attending clinic for investigation of dyspeptic symptoms. The aim is to document abnormal function of the stomach and intestines and to identify the causes of dyspeptic symptoms after a meal.
Conditions
- Functional Dyspepsia
Interventions
- OTHER
-
400ml of Liquid Nutrient Drink
12MBq Technetium-99m-DTPA will be added as a non-absorbable marker incorporated into liquid nutrient drink Fortisip Vanilla (Nutricia Clinical)
Sponsors & Collaborators
-
Nottingham University Hospitals NHS Trust
lead OTHER
Principal Investigators
-
Mark R Fox, MD · Univeristy Hopsitals Nottingham
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United Kingdom
Study Locations
More Related Trials
-
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
NCT05513040 ·Status: RECRUITING
-
Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method
NCT02151708 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia
NCT06931223 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Zhizhu Kuanzhong Capsule for Patients With Functional Dyspepsia-Postprandial Distress Syndrome
NCT04380233 ·Status: UNKNOWN ·Phase: NA
-
Optoacoustic Characterization of Postprandial Intestinal Blood Flow
NCT05160077 ·Status: COMPLETED ·Phase: NA
-
Elucidating Mechanisms That Underlie the Symptomatology of Functional Dyspepsia Using Novel Techniques and Its Therapeutic Validation Using Neuromodulators
NCT06213948 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Gastric Echography for Early Diagnosis of Nutritional Intolerance.
NCT05146908 ·Status: COMPLETED
-
Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia
NCT02113527 ·Status: COMPLETED
-
Gastric Emptying: in Vivo Studies in Healthy Volunteers
NCT02994472 ·Status: UNKNOWN ·Phase: NA
-
Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms
NCT07250308 ·Status: RECRUITING
-
International Clinical Study of Zhizhu Kuanzhong Capsule
NCT03825692 ·Status: UNKNOWN ·Phase: PHASE4
-
Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial
NCT01047800 ·Status: COMPLETED ·Phase: NA
-
Mucosal Barrier Defects in Functional Dyspepsia by Confocal Laser Endomicroscopy
NCT01006642 ·Status: UNKNOWN
-
Intestinal Dysmotility: Minute Rythm
NCT05230121 ·Status: COMPLETED
-
Abdominothoracic Muscular Tone in Functional Dyspepsia
NCT05417204 ·Status: COMPLETED ·Phase: NA
-
Image-Enhanced Endoscopy in the Gastrointestinal Tract
NCT04085211 ·Status: UNKNOWN
-
Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification
NCT01173484 ·Status: TERMINATED
-
Non-invasive Measurement of Gastric Motility
NCT04992884 ·Status: UNKNOWN
-
Contrast-enhanced Multispectral Optoacoustic Tomography for Functional Assessment of the Gastrointestinal Transit
NCT05933096 ·Status: RECRUITING ·Phase: NA
-
Study of Motilitone to Treat Functional Dyspepsia
NCT02365701 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Functional Dyspepsia With Acupuncture
NCT00786214 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia
NCT03004118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients
NCT03844100 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Acceptability and Tolerability of Magnetic Assisted Capsule Endoscopy Compared to Gastroscopy
NCT03420729 ·Status: COMPLETED ·Phase: NA